Source: Advanced Cell Technology, Inc.
Date: June 29, 2005
Summary:
WORCESTER, Mass. -- Advanced Cell Technology, Inc. and its collaborators reported the long-term transplantation of clone-derived stem cells in an animal model of aging. In this study, the cloned-derived stem cells showed an exponential (tenfold) competitive advantage over adult stem cells.